Sylvant 400 MG vials
Ended Awarded Last action
- Contract number
- SPE2DR26F9HL0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,983
Award facts
- Contract value 100% obligated
- $30,982.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $30,982.92 delivery order to AmerisourceBergen Drug Corp for SYLVANT 400 mg vials, with an ultimate completion date of January 20, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 comprehensive global pharmaceutical support vehicle valued through December 2026.
SYLVANT (siltuximab) is a specialty immunological medication used to treat select inflammatory conditions, and its procurement through the DLA medical supply chain supports military healthcare programs and related government medical systems. AmerisourceBergen's extensive federal contract portfolio demonstrates consistent capability to deliver specialized pharmaceutical products across multiple therapeutic domains through competitively awarded orders. The company's primary IDC vehicle with DLA Troop Support Medical enables flexible pharmaceutical sourcing to support military healthcare requirements globally, with ongoing strategic planning by DLA to establish next-generation pharmaceutical prime vendor contracts involving multiple regional contractors.
Quick answers
Who was awarded contract SPE2DR26F9HL0?
SPE2DR26F9HL0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 26, 2025.
How much is contract SPE2DR26F9HL0 worth?
The government has obligated $30,983 on SPE2DR26F9HL0.
Is contract SPE2DR26F9HL0 an order under another contract?
Yes. SPE2DR26F9HL0 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9HL0 competed?
The extent of competition for SPE2DR26F9HL0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award